XNYS · Healthcare · Diagnostics & Research
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-21 | Q1 2026 | 1.94 | 2.06 | +6.19% | $5.95B | ✅ Beat | +1.75% | -8.00% | -10.90% |
| 2026-01-28 | Q4 2025 | 2.17 | 2.23 | +2.76% | $6.84B | ✅ Beat | -0.11% | -2.23% | -6.19% |
| 2025-10-21 |
| Q3 2025 |
| 1.72 |
| 1.89 |
| +9.88% |
| $6.05B |
| ✅ Beat |
| — |
| — |
| — |
| 2025-07-22 | Q2 2025 | 1.64 | 1.80 | +9.76% | $5.94B | ✅ Beat | — | — | — |
| 2025-04-22 | Q1 2025 | 1.64 | 1.88 | +14.63% | $5.74B | ✅ Beat | — | — | — |
| 2025-01-29 | Q4 2024 | 2.16 | 2.14 | -0.93% | $6.54B | ❌ Miss | — | — | — |
| 2024-10-22 | Q3 2024 | 1.57 | 1.71 | +8.92% | $5.80B | ✅ Beat | — | — | — |
| 2024-07-23 | Q2 2024 | 1.57 | 1.72 | +9.55% | $5.74B | ✅ Beat | — | — | — |
Showing last 8 quarters.